What is Parabilis Medicines worth?
$920.0Mlast known valuation
Parabilis Medicines last raised $305.0M in its Later Stage VC (Series F) (Jan 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Parabilis Medicines
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series F) | $305.0M | ▮ | ▮ |
| Jan 2025 | Later Stage VC (Series E) | $145.0M | ▮ | ▮ |
| Nov 2022 | Later Stage VC (Series D) | $178.0M | ▮ | ▮ |
How Parabilis Medicines's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Parabilis Medicines, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Parabilis Medicines worth?
- Parabilis Medicines's implied valuation is $920.0M, based on the PA Mark composite price of about $27 per share as of Sep 2026.
- How much has Parabilis Medicines raised?
- Parabilis Medicines has raised $812.0M in total funding across 3 recorded rounds.
- When did Parabilis Medicines last raise?
- Parabilis Medicines last raised in Jan 2026 (Later Stage VC (Series F)), raising $305.0M.